Latest News
VAXIMM Starts Clinical Study of First Oral Cancer Vaccine
News Dec 13, 2011The Swiss-German biotech firm and Merck KGaA spin-off, have announced the start of the first clinical trial of its investigational oral therapeutic cancer vaccine VXM01.
READ MORE
Penn Study on Silencing of Tumor Suppressor Gene Suggests New Target for Lymphoma
News Dec 12, 2011Professors from the Perelman School of Medicine at the University of Pennsylvania, and their colleagues, found that a cancer-causing fusion protein works by silencing the tumor suppressor gene IL-2R common gamma-chain (IL-2R?). The results suggest news targets for lymphoma and other types of cancer.
READ MORE
Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial
News Dec 12, 2011Sunesis Pharmaceuticals, Inc. has announced that the independent Data and Safety Monitoring Board (DSMB) for the VALOR trial has completed a planned periodic safety review and recommended that the trial continue as planned without changes to study conduct.
READ MORE
4SC Obtains Key Patent for Lead Anti-Cancer Compound Resminostat in Japan
News Dec 12, 2011Japan, due to 4SC’s alliance with Yakult Honsha and the high incidence of liver cancer, is of high strategic importance for 4SC and the further development of resminostat.
READ MORE
Clarient and ACORN Research Announce Partnership
News Dec 09, 2011The strategic collaboration will focus around molecular testing of tumor samples.
READ MORE
Genomic Health Discovers New Gene Networks Associated with Breast Cancer
News Dec 09, 2011Study provides technical validation of whole transcriptome RNA-Seq as a powerful new tool for clinical research and development. Genomic Health will provide proprietary platform combining whole transcriptome profiling and mutation analysis for large clinical studies.
READ MORE
Israeli Scientist Conducts Cancer-Cell Gene Silencing Research
News Dec 09, 2011Dr. Shulamit Michaeli, who is the first professor to hold the David and Inez Myers Foundation chair in gene expression and infectious diseases at Bar-Ilan University in Israel, is conducting research specific to using gene silencing to target cancer cells, treat parasitic diseases, and provide novel therapies for type 1 diabetes.
READ MORE
Rosetta Genomics Announces New York State Approval for miRview mets²
News Dec 09, 2011Proprietary microRNA diagnostic for identification of cancer of unknown primary now available in all 50 U.S. states.
READ MORE
Tiny Genetic Variation can Predict Ovarian Cancer Outcome
News Dec 09, 2011New findings suggest a genetic test may help guide treatment of women with ovarian cancer.
READ MORE
Imaging Tool Tracks Carbon Nanotubes in Living Cells
News Dec 08, 2011Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine.
READ MORE
